In this study, we evaluated the anti‐cancer effects of sunitinib on SW579 cells to reveal whether or not KDR targeting could potentially be used as cancer therapy for advanced thyroid cancer patients. The gene discussed is KDR; the disease is thyroid gland carcinoma.